1. Home
  2. EPR vs FOLD Comparison

EPR vs FOLD Comparison

Compare EPR & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$58.44

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.32

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPR
FOLD
Founded
1997
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.4B
IPO Year
1997
2007

Fundamental Metrics

Financial Performance
Metric
EPR
FOLD
Price
$58.44
$14.32
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$57.94
$26.11
AVG Volume (30 Days)
825.5K
7.2M
Earning Date
02-25-2026
02-18-2026
Dividend Yield
6.05%
N/A
EPS Growth
N/A
N/A
EPS
2.29
N/A
Revenue
$707,150,000.00
$598,704,000.00
Revenue This Year
$5.12
$21.70
Revenue Next Year
$3.22
$18.91
P/E Ratio
$25.60
N/A
Revenue Growth
3.73
21.28
52 Week Low
$41.75
$5.51
52 Week High
$61.24
$14.38

Technical Indicators

Market Signals
Indicator
EPR
FOLD
Relative Strength Index (RSI) 69.93 79.28
Support Level $56.74 $14.30
Resistance Level $58.58 $14.36
Average True Range (ATR) 1.23 0.03
MACD 0.24 -0.09
Stochastic Oscillator 87.47 75.00

Price Performance

Historical Comparison
EPR
FOLD

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: